^
Contact us to learn more about
our Premium Content: News alerts, weekly reports and conference plannersDRUG:
ART0380
i
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
Artios Pharma
Drug class:
ATR inhibitor
Related drugs:
Phase 1/2
Artios Pharma Ltd
Recruiting
Last update posted :
04/03/2024
Initiation :
12/13/2020
Primary completion :
06/01/2025
Completion :
06/01/2025
ATM • HRD • BRCA
|
HRD • BRCA mutation
|
gemcitabine • irinotecan • ART0380
Phase 2
Artios Pharma Ltd
Recruiting
Last update posted :
01/05/2024
Initiation :
09/06/2023
Primary completion :
03/01/2025
Completion :
03/01/2025
PD-L1 • PD-1
|
ART0380
Share
